Podcasts about Electrophysiology

This week we replay an episode from 2 years ago on postoperative ectopic atrial tachycardia (EAT) following congenital heart surgery in children. Are there risk factors for this arrhythmia and are any modifiable? What is the 'go to' therapy used by the electrophysiologists at Children's LA for the acute and chronic treatment of this arrhythmia in the postoperative period? Is the presence of EAT in a postoperative congenital heart patient a marker for a worse outcome? These are amongst the questions posed to Children's of Los Angeles pediatric electrophysiologist, Dr. Jonathan Uniat. ·         DOI: 10.1007/s00246-022-03068-8

With Børge Nordestgaard and Anders Berg Wulff, Copenhagen University Hospital, Copenhagen - Denmark. Read the European Heart Journal - Cardiovascular Imaging paper Read the European Heart Journal - Cardiovascular Imaging editorial

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Vera Maslova, University Medical Center of Schleswig-Holstein, Kiel - Germany, Daniel Scherr Medical University of Graz, Austria, and Michal Farkowski, Ministry of Interior and Administration National Medical Institute, Warsaw, Poland. During this podcast Daniel Scherr, Michal Farkowski, Stefan Simovic and Vera Maslova will explore the newly published 2025 ESC-EHRA Atlas on Heart Rhythm Disorders, featured in EP Europace journal offering key insights into global arrhythmia care. 

CardioNerds guest host Dr. Colin Blumenthal joins Dr. Juma Bin Firos and Dr. Aishwarya Verma from the Trinity Health Livonia Hospital to discuss a fascinating case involving malignant ventricular arrhythmias. Expert commentary is provided by Dr. Mohammed Ali-Jazayeri. Audio editing for this episode was performed by CardioNerds Intern, Julia Marques Fernandes.  This case explores the puzzling presentation of exercise-induced ventricular tachycardia in a young, otherwise healthy male who suffered recurrent out-of-hospital cardiac arrests. With no traditional risk factors and an unremarkable ischemic workup, the challenge lay in uncovering the underlying cause of his malignant arrhythmias. Electrophysiology studies and advanced imaging played a pivotal role in systematically narrowing the differentials, revealing an unexpected arrhythmogenic substrate. This episode delves into the diagnostic dilemma, the role of EP testing, and the critical decision-making surrounding ICD placement in a patient with a concealed but life-threatening condition.  US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls- Malignant Ventricular Arrhythmias This case highlights the challenges and importance of diagnosing and managing ventricular arrhythmias in young, seemingly healthy individuals. Here are five key takeaways from the episode:  Electrophysiology (EP) studies play a crucial role in identifying arrhythmogenic substrates in patients with exercise-induced ventricular tachycardia (VT) without obvious structural heart disease. In this case, substrate mapping revealed late abnormal ventricular afterdepolarizations in the basal inferior left ventricle, providing valuable insights into the underlying mechanism.  Cardiac MRI can be a powerful tool for detecting subtle myocardial abnormalities. The subepicardial late gadolinium enhancement (LGE) in the lateral and inferior LV walls suggested an underlying myocardial process, even when other imaging modalities appeared normal.  The VT morphology can provide clues about the underlying mechanism. In this case, the right bundle branch block pattern with a northwest axis and shifting exit sites pointed towards a scar-mediated mechanism rather than a channelopathy or idiopathic VT.  Implantable cardioverter-defibrillator (ICD) placement is crucial for secondary prevention of sudden cardiac death (SCD) in patients with malignant ventricular arrhythmias, even in young individuals. The patient's initial deferral of ICD implantation highlights the importance of shared decision-making and patient education in these complex cases.  "Scar-mediated VT introduces the risk of new arrhythmogenic substrates over time, reinforcing the need for ICD therapy even when catheter ablation is considered." This pearl emphasizes the dynamic nature of the arrhythmogenic substrate and the importance of long-term risk mitigation strategies.  Notes - Malignant Ventricular Arrhythmias Notes were drafted by Juma Bin Firos.  1. What underlying pathologies cause ventricular arrhythmias in young patients without overt structural heart disease? Myocardial fibrosis: Detected via late gadolinium enhancement (LGE) on cardiac MRI Present in 38% of nonischemic cardiomyopathy cases Increases sudden cardiac death (SCD) risk 5-fold Often localized to subepicardial regions, particularly in the inferolateral left ventricle (LV) May precede overt systolic dysfunction by years Subclinical cardiomyopathy: 67% of young VT patients show subtle cardiac dysfunction Suggests VT may be the first manifestation of cardiomyopathy

Pacemakers, defibrillators and Afib are just a few terms related to electrical activity in the heart. Specialists called Electrophysiologists are specially trained to diagnose and treat irregular heart rhythms. Advanced Practice Provider Bryce Yantis tells us more about this interesting and growing specialty of medicine.Support the showSarah Bush Lincoln is a 150-bed, not-for-profit, regional health system located in East Central Illinois. Follow us on: Faceboook InstagramLinkedIn

In this episode of The EP Edit podcast, we speak with Olivia Gilbert, MD, MSc, FACC, about the new ACC Concise Clinical Guidance report on medical weight management for optimizing cardiovascular health.

With Edward Hulten, Brown University, Providence, and Islam Shatla, University of Kansas Medical Center, Kansas City, USA. Link to edi

With Emma Svennberg, Karolinska Institute, Stockholm -  Sweden, Sabine Ernst, Royal Brompton Hospital, London - UK, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Dominik Linz, Maastricht University Medical Centre (MUMC), Maastricht - The Netherlands. During this podcast, Emma Svennberg, Sabine Ernst, Stefan Simovic and Dominik Linz will tackle EHRA–ESC–HRS scientific statement sets new standards for trustworthy AI in electrophysiology, using a 29-item reporting checklist. EP Europace: State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology

This week we go back in time to 2022 to re-enter the world of cardiogenetics and electrophysiology when we review the topic of catecholaminergic polymorphic ventricular tachycardia (CPVT). Is there a 'best' beta blocker for the treatment of this condition? Why is one better than others? How should one manage the patient who is intolerant of beta blockade but needs it for prevention of arrhythmia? What is the role of flecainide, sympathectomy or even ICD's for these patients? PhD candidate and physician Dr. Puck Peltenburg and CPVT world authority, Dr. Christian van der Werf (both of University of Amsterdam) share their deep insights this week. doi: 10.1161/CIRCULATIONAHA.121.056018. Epub 2021 Dec 7

With Francesca Coraducci Marche Polytechnic University of Ancona, Ancona - Italy, Marco Guglielmo, University Medical Center Utrecht, Utrecht - The Netherlands, and Anna Giulia Pavon, Cardiocentro Ticino Institute, Lugano - Switzerland. Link to editorial Link to paper

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Jacopo Francesco Imberti, Modena Polyclinic Modena University Hospital, Modena - Italy, Haran Burri, Cardiology Department, University Hospital of Geneva - Switzerland and Michael Glikson, Jesselson Integrated Heart Center of Shaare Zedek Medical Center, Jerusalem - Israel. In this podcast, Haran Burri, Michael Glikson, Stefan Simovic and Jacopo Imberti will discuss Conduction system pacing indications. This 2025 EHRA Cardio Talk Keep the rhythm podcast series is supported by Medtronic in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

In this episode of JACC This Week, Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC spotlights major electrophysiology research and clinical insights from the July 8 issue of JACC. This week's issue features new findings on left atrial appendage occlusion techniques, comparisons of atrial fibrillation stroke prevention guidelines across regions, and device-related complications such as pacemaker lead perforation and device embolization. You'll also hear highlights from JACC: Clinical Electrophysiology, including striking Amara Yad anatomical visuals and real-world clinical scenarios.

With Frank Flachskampf, Uppsala University, Uppsala - Sweden, and James Thomas, Northwestern University, Chicago - USA.  Link to editorial  Link to paper  

Electrophysiology Considerations in Oncology Patients   Guest: Nicholas Tan, M.D., M.S. Host: Anthony H. Kashou, M.D.   In today's episode of ECG Making Waves, Dr. Anthony Kashou interviews Dr. Nicholas Tan on how clinicians should consider electrophysiology in the patient with cancer. After listening to this episode, learners will understand the relationship between cancer and heart rhythm disorders, as well as begin to appreciate how cancer and arrhythmia treatments can interact.   Topics Discussed: Why are arrhythmias even relevant in cancer patients? What are some key arrhythmias associated with cancer or their therapies? What is a general approach towards managing arrhythmias in cancer patients? Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

This week we speak with Assistant Professor of Pediatrics at Harvard Medical School, Dr. Audrey Dionne about a recent work she co-authored on the topic of outcomes of ablation in the early postoperative period following congenital heart surgery. Who is a candidate for this intervention and what were the outcomes? How commonly were serious complications encountered and how successful were these procedures? Dr. Dionne reviews these and other aspects of this novel review this week. https://doi.org/10.1016/j.hrthm.2024.08.061

With David Duncker, Hannover Heart Rhythm Center, Hannover - Germany, Marco Metra, University of Brescia, Brescia - Italy, Micaela Ebert, Heart Center, University Hospital Dresden, Dresden - Germany, and Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia  During this podcast Marco Metra, David Duncker, Stefan Simovic & Mica Ebert will discuss sudden cardiac death prevention (SCD) in patients with heart failure and reduced ejection fraction (HFrEF). This 2025 EHRA Cardio Talk Keep the rhythm podcast series is supported by ZOLL Cardiac Management Solutions in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsors.

With Damiano Fedele, University of Bologna, Bologna - Italy and University Medical Center Utrecht - The Netherlands, Marco Guglielmo, University Medical Center Utrecht, Utrecht - The Netherlands, and Anna Giulia Pavon, Cardiocentro Ticino Institute, Lugano - Switzerland. Link to editorial Link to paper 

Check out the TIES Sales Showdown at www.tx.ag/TIESVisit The Sales Lab at https://thesaleslab.org and check out all our guests' recommended readings at https://thesaleslab.org/reading-listTo listen to The Sales Lab Podcast on your favorite apps, visit https://thesaleslab.simplecast.com/ and select your preferred method of listening.Connect with us on Facebook at https://www.facebook.com/saleslabpodcastConnect with us on Linkedin at https://www.linkedin.com/company/thesaleslabSubscribe to The Sales Lab channel on YouTube at  https://www.youtube.com/channel/UCp703YWbD3-KO73NXUTBI-Q 

Prof. Marina de Koning-Tijssen interviews Professors Anna Latorre and Shabbir Merchant on the topic of electrophysiology, with a focus on cortical myoclonus. Together they discuss the potential applications of electrophysiology for myoclonus in clinical practice. They also explore the complex interface between cortical myoclonus and epilepsy.

With Jean-Claude Deharo, Hospital La Timone Adults, Marseille - France, Professor Fabien Praz, Inselspital Bern - Switzerland, Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia and Vera Maslova, University Medical Center of Schleswig-Holstein, Kiel - Germany. This episode will tackle the EHRA Consensus document on management of patients with transvalvular leads undergoing percutaneous tricuspid clave interventions, focusing on assessment, procedural insights, post-procedure care, and expert perspectives.

Meredith Cochran is a serial entrepreneur with a passion for authentic conversations and high quality craftsmanship. A roll-up-your-sleeves kind of girl. Meredith has a background in Cellular Molecular Biology, Electrophysiology, and Traditional Chinese Medicine. She uses this experience to pursue her passion of preventive health and food-as-medicine. Meredith is an accomplished author and founder of a BFY brand which generates multi-million dollar revenues annually with an omni-channel business model. She is currently focused on her role as Director of Marketing for one of the largest privately-owned businesses in the world and her new startup, which focuses on sustainably sourced teas formulated with the intention of reconnecting us to our body, mind, soul, and those who surround us. In her spare time, she enjoys time with her dog, Maui, bikram yoga, and reading.Elevate Your Brand is the #1 marketing podcast for entrepreneurs and “wantrepreneurs” looking for insider tips and secrets from the most exciting new and growing brands in Los Angeles and the US at large. Each week, entrepreneurial special guests join Laurel Mintz, founder and CEO of award-winning marketing agency Elevate My Brand, to discuss the marketing failures and successes that have brought their brands to the next level. Learn from real-life experiences and be inspired by leaders in your industry about how smart digital and experiential marketing can elevate your brand.Contact us: https://www.elevatemybrand.com/contact Stay connected & DM us feedback on the podcast:Instagram: https://www.instagram.com/elevatemybrandla/ LinkedIn: https://www.linkedin.com/company/elevatemybrandla/ TikTok: https://www.tiktok.com/@elevatemybrand

This special electrophysiology-themed issue of JACC, summarized by Dr. Valentin Fuster, dives into cutting-edge research on atrial fibrillation, pulsed field ablation, sudden cardiac arrest in athletes, and preventive strategies in congenital heart disease. From new therapies like finerenone to breakthrough mapping techniques, this episode captures the evolving sophistication and promise of arrhythmia management in modern cardiology.

With Giovanni Donato Aquaro, University of Pisa - Italy, and Carmelo De Gori, Fondazione Monasterio, Pisa - Italy. Link to editorial Link to paper  

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Stelios Tzeis, Mitera Hospital, Athens - Greece, and Natasja de Groot, Erasmus University Medical Centre, Rotterdam - The Netherlands, and Dominik Linz, Maastricht University Medical Centre (MUMC), Maastricht - The Netherlands. During this podcast Stefan Simovic, Natasja de Groot, Stylianos Tzeis and Dominik Linz will tackle the EHRA 2025 Highlights  (scientific breakthroughs, major trial results, latest news on in catheter ablation and leadless pacing). 

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

This week we review a recent review paper on newest innovations and literature on pacing in pediatric patients and learn a bit about such diverse pediatric pacing topics as:Use of the Medtronic Micra device in an off-label manner for epicardial pacing in small infantsNovel, less invasive approaches to placing epicardial leads in small childrenThe role of leadless pacing in the pediatric or CHD patientConduction system pacing in 2025 in the congenital patientThe above are amongst the potpourri of pacing topics that we review with noted congenital electrophysiologist, Dr. Charles Berul of Children's National Hospital in Washington, DC in a co-branded episode with the SADS Foundation. For more information on SADS, please go to their website: SADS.ORG.DOI: 10.1016/j.hrthm.2024.02.011

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, and Gregory Y.H. Lip, University of Liverpool, Liverpool - UK. This episode will tackle the current status and management of subclinical atrial fibrillation and atrial high rate episodes.

With Federico Fortuni and Claudio Bernetti, University of Perugia, Perugia - Italy Link to paper Link to editorial

Returning for a second study this month, the JHLT Digital Media Editors invite lead author Oliver J.F. Weiner, to discuss the paper, “Sympathetic reinnervation in cardiac transplant recipients: Prevalence, time course, and association with long-term survival.” Dr. Weiner is currently an out of training registrar at Monash Health in Melbourne, Australia, but will soon return to his home of the UK to begin internal medicine training with the intention becoming a cardiologist. He is especially interested in advanced heart failure and electrophysiology. The episode explores: The uncertainty around clinical influences on reinnervation The importance of this single-center study in expanding the literature Potential future treatment options   For the latest studies from JHLT, visit www.jhltonline.org/current, or, if you're an ISHLT member, access your Journal membership at www.ishlt.org/jhlt. Those on lung transplant teams should check the previous episode for a study on recent trends and post-transplant outcomes from EVLP. Don't already get the Journal and want to read along? Join the International Society of Heart and Lung Transplantation at www.ishlt.org for a free subscription, or subscribe today at www.jhltonline.org.

With Lucas Boersma, St.Antonius Hospital, Nieuwegein - The Netherlands, and Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia. Join us for an exciting episode on non-transvenous ICDs, exploring their advantages and future potential.  

In this episode of "In the Rhythm," we welcome Drs. Hawkins Gay from Northwestern Medicine and Mohamed Elshazly of Orlando Health to explore the transformative role of artificial intelligence in Electrophysiology. Join us as they delve into the innovative ways AI is reshaping the diagnosis, prediction, and treatment of arrhythmias, from enhancing patient outcomes to streamlining clinical workflows.

With Markus Meyer, Lillehei Heart Institute, University of Minnesota - USA, Tim Van Loon and Joost Lumens, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands. Link to paper Link to editorial

This week we review a recent report that asks the question, 'Do all infants who present with SVT require preventive anti-arrhythmic medical therapy?' Who might be a candidate for not using an anti-arrhythmia medication in infancy? What sort of parental education is needed to potentially not use medicine and how do patients not treated compare to those who were treated with anti-arrhythmics in regards to re-admission or presentation to the emergency department or development of tachycardia induced cardiomyopathy? How should parents assess their infants for SVT at home? How long should infants be monitored prior to discharge to home after a single uncomplicated episode of SVT? We speak with Assistant Professor of Pediatrics at Washington University and the first author of this week's work, Dr. Anthony Pompa. DOI: 10.1007/s00246-023-03263-1

With Doctor Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Serge Trines, Leiden University Medical Center, Leiden - The Netherlands and Philip Moore, St Bartholomew's Hospital, London - UK This episode focuses on the EHRA Updated Core Curriculum.

With Irene Carrion-Sanchez and Jose Luis Zamorano, Ramon and Cajal University Hospital, Madrid - Spain. Link to paper Link to editorial

Jasmina (Jass) Brooks is President, Electrophysiology, Johnson & Johnson MedTech (formerly Biosense Webster, Inc.), a global leader in the science, diagnosis and treatment of heart rhythm disorders. Jass is a seasoned leader with more than 25 years of experience in the cardiovascular field, primarily focused on electrophysiology. She has accountability for setting the J&J MedTech Electrophysiology end-to-end global strategy as a leader in cardiac ablation, advancing its innovation agenda, and driving execution to position the organization for continued growth. Previously, Jass was Vice President, Global Strategic Marketing, Biosense Webster, Inc. In this role, she worked with cross-functional and international teams to set the strategy and shape the company product pipeline to drive growth, market share, and profitability. Having joined Biosense Webster in 2014, Jass held positions of increasing scope and responsibility in the Global Strategic Marketing Organization. Prior to joining Johnson & Johnson, Jass spent 15 years at GE Healthcare, where she held various roles in commercial marketing, global strategic marketing, product development and engineering in the US and EMEA. She holds a Bachelor of Science in Biomedical Engineering from Louisiana Tech University. Jass has dedicated her career to championing excellence in patient outcomes and solving unmet medical needs. She is a collaborative leader with a deep knowledge of the electrophysiology space, a track record of successfully driving growth and market leadership, as well as a deep commitment to developing talent and fostering a culture of collaboration and inclusivity. In 2023, Jass was named as one of LA Times' Healthcare Visionaries. In 2024, she was honored as one of Orange County Business Journal's Women in STEM and was also celebrated as one of the publications 2024 “OC 500,” an annual Directory of Influence that honors the most impactful leaders, innovators, and changemakers in the OC business community. -- Critical Mass Business Talk Show is Orange County, CA's longest-running business talk show, focused on offering value and insight to middle-market business leaders in the OC and beyond. Hosted by Ric Franzi, business partner at REF Orange County.

With Shinwan Kany, The University Medical Center Hamburg-Eppendorf, Hamburg - Germany, and Shaan Khurshid, Massachusetts General Hospital and Harvard Medical School - USA. Link to paper Link ton editorial

DISCLAMER >>>>>>    The Ditch Lab Coat podcast serves solely for general informational purposes and does not serve as a substitute for professional medical services such as medicine or nursing. It does not establish a doctor/patient relationship, and the use of information from the podcast or linked materials is at the user's own risk. The content does not aim to replace professional medical advice, diagnosis, or treatment, and users should promptly seek guidance from healthcare professionals for any medical conditions.   >>>>>> The expressed opinions belong solely to the hosts and guests, and they do not necessarily reflect the views or opinions of the Hospitals, Clinics, Universities, or any other organization associated with the host or guests.       Disclosures: Ditch The Lab Coat podcast is produced by (Podkind.co) and is independent of Dr. Bonta's teaching and research roles at McMaster University, Temerty Faculty of Medicine and Queens University. Welcome to another episode of "Ditch the Lab Coat," where we break down complex medical science in an engaging and relatable way. In today's episode, our hosts, Dr. Mark Bonta and Dr. Zachary Laksman, dive deep into the nuances of managing atrial fibrillation (AFib). We'll dissect the foundation and challenges of current treatment guidelines, explore the growing role of atrial fibrillation ablation, and discuss the fascinating phenomenon of "Holiday Heart."Dr. Laksman will also share insights from his cutting-edge work at the intersection of genetics and personalized medicine, including the innovative MyTrials AI platform he's co-founded. This tool aims to democratize access to clinical trials using artificial intelligence, making them accessible irrespective of personal networks. We'll cover the emerging potential of wearables in heart rhythm monitoring, the importance of lifestyle interventions, and the evolving landscape of AFib treatment.Whether you're a medical professional or simply curious about heart health, this episode offers valuable perspectives and practical advice. Stay tuned as we unravel these topics and more with the expertise of Dr. Zachary Laksman, an acclaimed heart rhythm specialist and leader in cardiogenetics. Don't forget to check out our new website and engage with us for more insightful content. Let's get started!00:00 - Seek professional advice, not podcast opinions.05:50 - Wearable devices: Reliable, clinically relevant, widely used.08:50 - Heart doctor: Electrician managing heart's nerve impulses.12:50 - Atrial fibrillation increases stroke risk despite rhythm.14:19 - Smartwatch inconsistencies in detecting atrial fibrillation.19:33 - Rhythm control improves life quality and longevity.20:17 - Modifiable and unmodifiable risk factors affect atrial fibrillation.25:56 - Researching interventions for high-risk patient outcomes.28:24 - Lifestyle changes reduce recurrent atrial fibrillation likelihood.31:10 - Shock hearts carefully; consider anticoagulants beforehand.33:52 - Are guidelines fear-mongering or evidence-based?37:55 - Electrophysiology advances improve atrial fibrillation ablation.41:54 - Tailoring medicine to individuals for better outcomes.46:02 - AI aids connection, education, breaking trial barriers.48:43 - Helping people navigate medical concerns and care.53:44 - Heart rhythms, paddles, blood thinners, stroke prevention.55:27 - Zach's AI project expands clinical trial access.

In this episode, Dr. Kamala Tamirisa, a cardiac electrophysiologist at Texas Cardiac Arrhythmia Institute, discusses the importance of increasing female representation in cardiology, the barriers women face in leadership, and the power of allyship. Dr. Tamirisa shares her insights on fostering an abundance mindset, creating supportive work environments, and mentoring the next generation of women leaders.

This week we review a recent large scale study on catecholaminergic polymorphic ventricular tachycardia (CPVT) in children which is based on two large international registries. How do outcomes differ between those symptomatic CPVT patients treated with or without an ICD? Who amongst symptomatic CPVT pediatric patients likely warrant an ICD? What sort of ICD might be optimal - subcutaneous or transvenous? Are there ways to program ICD's in CPVT patients that may reduce inappropriate shocks? Why should the ICD be rarely employed in the CPVT pediatric patient? These are amongst the questions reviewed this week on the podcast. We speak with the work's senior author, Dr. Shubhayan Sanatani who is the chief of pediatric cardiology at BC Children's Hospital in Vancouver, British Columbia, Canada. doi: 10.1016/j.hrthm.2024.04.006. Epub 2024 Apr 7.

This week we listen in on a lecture by Assistant Professor of Pediatrics at the University of Pennsylvania, Dr. Christopher Janson, on the novel agent ivabradine. How does this agent work and in what circumstances can it be used in pediatric arrhythmia management? Is this safe to use for critical arrhythmias despite the fact that it is, at present, only available as an enteral agent? What is the proper dosing regimen with this medication? Dr. Janson answers these and many more questions about ivabradine in this lecture from the Pedirhythm XI conference in Rome, Italy on 9/20/24. 

In this episode, Katie interviews Meredith Cochran. Meredith  is a serial entrepreneur with a passion for authentic conversations and high-quality craftsmanship. Meredith has a Cellular Molecular Biology, Electrophysiology, and Traditional Chinese Medicine background. She uses this experience to pursue her passion for preventive health and food-as-medicine. Meredith is an accomplished author and former CEO/founder of The Osso Good Co., which she grew to an omnichannel business model and millions in revenue. She is currently focused on her role as Founder/CEO of Shareable (www.meredithcochran.com), where she operates as a fractional marketing team for several CPG brands including one of the largest privately-owned businesses in the World (www.pasturebird.com) and her new startup, Tēthos (www.drinktethos.com), which focuses on sustainably sourced teas and na wines. In her spare time, she serves on the board for a nonprofit, Berry Good Food Foundation (www.berrygoodfood.org) aimed at solving food sovereignty in San Diego and Baja.Key Topics Discussed:Overview of Meredith's non-alcoholic wine companyThe inspiration behind creating a healthier wine optionMeredith's transition from her previous career to entrepreneurshipKey challenges faced in the startup process and how she overcame themInsights on how Meredith's products align with a healthier lifestyleDiscussion on the growing demand for non-alcoholic and healthy beverage optionsTips and insights for those looking to start their own businessesThe significance of perseverance and passion in entrepreneurshipLearn more about Tēthos and follow along to join in on the conversation: https://www.instagram.com/drink.tethos/https://drinktethos.com/

Send us a textOne of the most treated heart rhythm disorders in the United States is irregular heart activity known as Atrial Fibrillation or Afib. Dr. Weiwei Li, electrophysiologist at St. Luke's Heart Care Clinic, returns to the podcast to discuss a new treatment option for Afib, Pulsed Field Ablation.To learn more about heart care services at St. Luke's, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.

This week we delve into the world of electrophysiology and review a recent report from the team at Primary Children's hospital on the use of intravascular ultrasound for EP ablation procedures in children. How is this technology useful for ‘routine' ablations in kids? Are there some forms of tachycardia where its use is more important than others? How does it lower procedural time or improve efficacy? We speak with Dr. Thomas Pilcher, chief of pediatric electrophysiology at Primary Children's about his center's recent report in the use of this technology for ablation in children and those with congenital heart disease. https://doi.org/10.1093/europace/euae047

This week we go back in time to 20222 to re-review an episode focusing on gender disparities in salary in the field of congenital electrophysiology. To what degree are female electrophysiologists paid less than their male counterparts despite similar levels of education, work effort and seniority? What interventions could be enacted to help 'mind the gap' and level the playing field in this regard? We speak with the chief of pediatric electrophysiology at The Children's Hospital of Philadelphia, Professor Maully Shah, who is the first author of this week's research letter. doi: 10.1016/j.jacep.2022.02.011

Screening echo, multivitamins, wasteful research, another PA sensor for HF, vascular closure devices, and GLP-1 marketing as science research are the topics John Mandrola, MD, discusses this week. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Screening for Valvular HD in the Elderly EHJ-CV Imaging Paper https://doi.org/10.1093/ehjci/jeae127 II. Vitamins and Wasteful Research Is Red Meat Healthy? Multiverse Analysis Has Lessons Beyond Meat   https:// www.medscape.com/viewarticle/red-meat-healthy-multiverse-analysis-has-lessons-beyond-meat-2024a10008qv May 10, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1000772 Multivitamin Paper https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820369 Physicians Health Study II https://jamanetwork.com/journals/jama/fullarticle/1389615 III. FDA Has Approved Another PA Sensor Link to slides https://c212.net/c/link/?t=0&l=en&o=4104690-1&h=4197477262&u=https%3A%2F%2Fendotronix.com%2FEndotronix-PROACTIVE-HF-LBCT-THT-2024.pdf&a=here IV. Vascular Closure Devices in Electrophysiology. Vascular Closure Devices Study  https://onlinelibrary.wiley.com/doi/full/10.1111/jce.16345 V. SURMOUNT-OSA SURMOUNT OSA Paper https://www.nejm.org/doi/full/10.1056/NEJMoa2404881 SELECT https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 June 21, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1001237 JAMA Systematic Review and Meta-analysis https://jamanetwork.com/journals/jama/fullarticle/2643307 SAVE https://www.nejm.org/doi/full/10.1056/NEJMoa1606599 Norwegian study https://doi.org/10.1016/j.hrthm.2022.06.016 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net